Peer‑Reviewed Study Confirms ABL Diagnostics’ CE‑IVD Whole‑Genome HIV‑1 Assay as a Global First

Independent clinical validation strengthens ABL’s leadership in the fast‑growing HIV drug‑resistance testing market ABL ...